Form 4 Filing for 10x Genomics, Inc.

This filing details transactions made by Shehnaaz Suliman, a director at 10x Genomics, Inc. On June 16, 2026, Suliman sold 5,359 shares of Class A Common Stock at a weighted average price of $32.589 per share, under a Rule 10b5-1 trading plan. This transaction resulted in 32,086 shares owned post-transaction. Additionally, 364 shares of Class A Common Stock were sold at a weighted average price of $33.2738 per share, also under the same trading plan, leaving 31,722 shares owned post-transaction. The transactions were executed through multiple trades, with prices ranging from $32.03 to $33.49. Suliman is providing full details of each sale price upon request.